Sadie Whittaker, Ph.D.

Sadie Whittaker, Ph.D. has a wealth of experience in the medical and public health fields. Sadie began their career in 2004 at Amgen, where they held positions as US Medical Lead for Biosimilars, Director of Clinical Development, and Senior Manager of Medical Writing. In 2014, they joined KYNE as Senior Vice President of Clinical and Medical Affairs, where they led the development of medical affairs, external engagement, and communications strategies for a variety of clients. In 2018, they joined the Solve ME/CFS Initiative as Chief Scientific Officer. In 2021, they joined Cellevolve as Chief External Affairs Officer and Acting Head of Clinical Development. Prior to joining Cellevolve, they were the Founder and CEO of ScienceOne, a consultancy focused on making an impact in public and population health.

Sadie Whittaker, Ph.D. began their educational journey in 1993 when they attended the University of Leeds and earned a Bachelor of Science (BSc) in Biochemistry and Molecular Biology in 1996. Sadie then continued their studies at the University of Birmingham, where they earned a Doctor of Philosophy (PhD) in Biological Sciences in 2001.